25. 進行性多巣性白質脳症 Progressive multifocal leukoencephalopathy Clinical trials / Disease details

臨床試験数 : 26 /  薬物数 : 35 - (DrugBank : 22) / 標的遺伝子数 : 8 - 標的パスウェイ数 : 37

  
4 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04781309
(ClinicalTrials.gov)		May 5, 20213/3/2021NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients With Progressive Multifocal LeukoencephalopathyA Pilot Study of NT-I7, a Long-Acting Recombinant IL-7 Molecule, as an Immune Reconstitution Strategy for Lymphopenia in Patients With Progressive Multifocal LeukoencephalopathyProgressive Multifocal LeukoencephalopathyDrug: NT-I7National Institute of Neurological Disorders and Stroke (NINDS)NULLRecruiting18 YearsN/AAll12Early Phase 1United States
2EUCTR2012-000725-41-GB
(EUCTR)		22/01/201304/09/2012A randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal LeukoencephalopathyA randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal Leukoencephalopathy. - INVICTUS HIV-infected patients with Progressive Multifocal Leukoencephalopathy
MedDRA version: 15.0;Level: PT;Classification code 10036807;Term: Progressive multifocal leukoencephalopathy;System Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]		Product Name: Recombinant human interleukin-7
Product Code: CYT107
INN or Proposed INN: N/A
Other descriptive name: Recombinant human interleukin-7		Cytheris S.A.NULLNot RecruitingFemale: yes
Male: yes		57Phase 2United States;European Union;Spain;Italy;Switzerland;United Kingdom
3EUCTR2012-000725-41-ES
(EUCTR)		12/12/201214/09/2012A randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal LeukoencephalopathyA randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal Leukoencephalopathy. - INVICTUS HIV-infected patients with Progressive Multifocal Leukoencephalopathy
MedDRA version: 15.0;Level: PT;Classification code 10036807;Term: Progressive multifocal leukoencephalopathy;System Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]		Product Name: Recombinant human interleukin-7
Product Code: CYT107
INN or Proposed INN: N/A
Other descriptive name: Recombinant human interleukin-7		Cytheris S.A.NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes		57Phase 2United States;European Union;Spain;United Kingdom;Switzerland
4EUCTR2012-000725-41-IT
(EUCTR)		08/11/201211/12/2012A randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal LeukoencephalopathyA randomized, placebo controlled, multicenter phase IIb study of human recombinant Interleukin-7 (CYT107) in HIV-related Progressive Multifocal Leukoencephalopathy - INVICTUS HIV-infected patients with Progressive Multifocal Leukoencephalopathy
MedDRA version: 14.1;Level: SOC;Classification code 10021881;Term: Infections and infestations;System Organ Class: 10021881 - Infections and infestations;Therapeutic area: Diseases [C] - Virus Diseases [C02]		Product Name: Recombinant human interleukin-7
Product Code: CYT107
Other descriptive name: Recombinant human interleukin-7		CYTHERISNULLNot RecruitingFemale: yes
Male: yes		57Phase 2United States;Spain;United Kingdom;Switzerland;Italy